Pages that link to "Q31121321"

The following pages link to VEGFR1 and VEGFR2 involvement in extracellular galectin-1- and galectin-3-induced angiogenesis (Q31121321):

Displaying 40 items.

• Glycosylation-dependent lectin-receptor interactions preserve angiogenesis in anti-VEGF refractory tumors (Q24337334) (← links)
• Galectin-3 Determines Tumor Cell Adaptive Strategies in Stressed Tumor Microenvironments (Q26744513) (← links)
• Regulatory role of glycans in the control of hypoxia-driven angiogenesis and sensitivity to anti-angiogenic treatment (Q26991865) (← links)
• Canonical and noncanonical vascular endothelial growth factor pathways: new developments in biology and signal transduction (Q27342723) (← links)
• Galectin-3 in angiogenesis and metastasis. (Q27687444) (← links)
• The Role of Galectin-1 in Cancer Progression, and Synthetic Multivalent Systems for the Study of Galectin-1 (Q28075523) (← links)
• Targeting vascular endothelial growth factor receptor 2 and protein kinase D1 related pathways by a multiple kinase inhibitor in angiogenesis and inflammation related processes in vitro (Q28546317) (← links)
• Galectin-1 expression imprints a neurovascular phenotype in proliferative retinopathies and delineates responses to anti-VEGF (Q33779141) (← links)
• RECK controls breast cancer metastasis by modulating a convergent, STAT3-dependent neoangiogenic switch (Q35130808) (← links)
• Serum galectin-3 as a potential marker for gastric cancer (Q35207994) (← links)
• Protein glycosylation in cancer (Q35413473) (← links)
• Myoblast-conditioned media improve regeneration and revascularization of ischemic muscles in diabetic mice (Q35606014) (← links)
• A novel PI3K inhibitor iMDK suppresses non-small cell lung Cancer cooperatively with A MEK inhibitor (Q35798191) (← links)
• The luteotrophic function of galectin-1 by binding to the glycans on vascular endothelial growth factor receptor-2 in bovine luteal cells (Q36215122) (← links)
• Aflibercept Traps Galectin-1, an Angiogenic Factor Associated with Diabetic Retinopathy (Q36357723) (← links)
• Chemically modified, non-anticoagulant heparin derivatives are potent galectin-3 binding inhibitors and inhibit circulating galectin-3-promoted metastasis. (Q36414261) (← links)
• Galectin-1 mediates TGF-β-induced transformation from normal fibroblasts into carcinoma-associated fibroblasts and promotes tumor progression in gastric cancer (Q36879539) (← links)
• Galectin-1 and -9 in angiogenesis: a sweet couple. (Q38214807) (← links)
• Galectins and neovascularization in central nervous system tumors (Q38214808) (← links)
• A potential pathophysiological role for galectins and the renin-angiotensin system in preeclampsia (Q38246351) (← links)
• Evolving mechanistic insights into galectin functions (Q38254055) (← links)
• Galectins in tumor angiogenesis (Q38269050) (← links)
• Galectin-3 disruption impaired tumoral angiogenesis by reducing VEGF secretion from TGFβ1-induced macrophages (Q38758852) (← links)
• Continuous administration of bevacizumab plus capecitabine, even after acquired resistance to bevacizumab, restored anti-angiogenic and antitumor effect in a human colorectal cancer xenograft model (Q38761451) (← links)
• Galectin-1 suppression delineates a new strategy to inhibit myeloma-induced angiogenesis and tumoral growth in vivo (Q38764048) (← links)
• Cancer-associated fibroblasts promote angiogenesis in gastric cancer through galectin-1 expression (Q38839374) (← links)
• Glycodendrimers: tools to explore multivalent galectin-1 interactions (Q41925209) (← links)
• Role of Galectins in Multiple Myeloma (Q47282400) (← links)
• Galectins and Carcinogenesis: Their Role in Head and Neck Carcinomas and Thyroid Carcinomas (Q47438594) (← links)
• Glycosylation as a Main Regulator of Growth and Death Factor Receptors Signaling (Q49805726) (← links)
• Galectin-3 Serum Levels Could Help Clinicians Screen for Salivary Gland Tumor Patients (Q52630484) (← links)
• Galectin-1 Controls the Proliferation and Migration of Liver Sinusoidal Endothelial Cells and Their Interaction With Hepatocarcinoma Cells. (Q53284113) (← links)
• Immune-Mediated and Hypoxia-Regulated Programs: Accomplices in Resistance to Anti-angiogenic Therapies. (Q53743967) (← links)
• The Role of Galectins in Cervical Cancer Biology and Progression. (Q55152503) (← links)
• Thiodigalactoside-Bovine Serum Albumin Conjugates as High-Potency Inhibitors of Galectin-3: An Outstanding Example of Multivalent Presentation of Small Molecule Inhibitors. (Q55379330) (← links)
• Galectin-1 gene silencing inhibits the activation and proliferation but induces the apoptosis of hepatic stellate cells from mice with liver fibrosis (Q58574738) (← links)
• Neuropilins in the Context of Tumor Vasculature (Q64275592) (← links)
• Neuropilin: Handyman and Power Broker in the Tumor Microenvironment (Q89587291) (← links)
• Cathepsin L-induced galectin-1 may act as a proangiogenic factor in the metastasis of high-grade serous carcinoma (Q91590494) (← links)
• Placental Galectins Are Key Players in Regulating the Maternal Adaptive Immune Response (Q91638842) (← links)